[go: up one dir, main page]

WO2019203771A3 - Solid oral pharmaceutical compositions comprising sitagliptin - Google Patents

Solid oral pharmaceutical compositions comprising sitagliptin Download PDF

Info

Publication number
WO2019203771A3
WO2019203771A3 PCT/TR2019/050139 TR2019050139W WO2019203771A3 WO 2019203771 A3 WO2019203771 A3 WO 2019203771A3 TR 2019050139 W TR2019050139 W TR 2019050139W WO 2019203771 A3 WO2019203771 A3 WO 2019203771A3
Authority
WO
WIPO (PCT)
Prior art keywords
sitagliptin
pharmaceutical compositions
solid oral
oral pharmaceutical
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2019/050139
Other languages
French (fr)
Other versions
WO2019203771A2 (en
Inventor
Ali Turkyilmaz
Seval Ataman
Cagil ERKAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Priority to EP19788122.0A priority Critical patent/EP3781135A4/en
Publication of WO2019203771A2 publication Critical patent/WO2019203771A2/en
Publication of WO2019203771A3 publication Critical patent/WO2019203771A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to solid oral pharmaceutical compositions comprising sitagliptin and a pharmaceutically acceptable excipient thereof, providing high stability and improved dissolution profile.
PCT/TR2019/050139 2018-04-17 2019-03-06 Solid oral pharmaceutical compositions comprising sitagliptin Ceased WO2019203771A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19788122.0A EP3781135A4 (en) 2018-04-17 2019-03-06 Solid oral pharmaceutical compositions comprising sitagliptin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2018/05447 2018-04-17
TR201805447 2018-04-17

Publications (2)

Publication Number Publication Date
WO2019203771A2 WO2019203771A2 (en) 2019-10-24
WO2019203771A3 true WO2019203771A3 (en) 2020-01-16

Family

ID=68240633

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050139 Ceased WO2019203771A2 (en) 2018-04-17 2019-03-06 Solid oral pharmaceutical compositions comprising sitagliptin

Country Status (2)

Country Link
EP (1) EP3781135A4 (en)
WO (1) WO2019203771A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020018034A2 (en) * 2018-04-17 2020-01-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Oral pharmaceutical compositions comprising dpp-4 inhibitor
JP7423264B2 (en) * 2019-10-17 2024-01-29 日本ジェネリック株式会社 Sitagliptin-containing tablets
CN114828831A (en) * 2019-12-24 2022-07-29 韩美药品株式会社 Compound preparation containing sitagliptin and dapagliflozin and preparation method thereof
CN111481520A (en) * 2020-06-15 2020-08-04 千辉药业（安徽）有限责任公司 Sitagliptin phosphate tablet
CN112843010A (en) * 2020-12-29 2021-05-28 浙江华海药业股份有限公司 Sitagliptin pharmaceutical composition and preparation process thereof
CN114159401A (en) * 2021-11-18 2022-03-11 苏州天马医药集团天吉生物制药有限公司 Sitagliptin phosphate tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014057059A1 (en) * 2012-10-11 2014-04-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Effervescent cefdinir formulation
WO2014174469A1 (en) * 2013-04-25 2014-10-30 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising a combination of sitagliptin and metformin
EP2853257A1 (en) * 2013-09-12 2015-04-01 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of linagliptin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120258170A1 (en) * 2009-05-20 2012-10-11 Nutracryst Therapeutics Private Limited Pharmaceutical co-crystals of quercetin
EP2295083A1 (en) 2009-09-15 2011-03-16 Ratiopharm GmbH Pharmaceutical composition comprising active agents metformin and sitagliptin or vildagliptin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014057059A1 (en) * 2012-10-11 2014-04-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Effervescent cefdinir formulation
WO2014174469A1 (en) * 2013-04-25 2014-10-30 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising a combination of sitagliptin and metformin
EP2853257A1 (en) * 2013-09-12 2015-04-01 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of linagliptin

Also Published As

Publication number Publication date
EP3781135A4 (en) 2021-12-29
WO2019203771A2 (en) 2019-10-24
EP3781135A2 (en) 2021-02-24

Similar Documents

Publication Publication Date Title
WO2019203771A3 (en) Solid oral pharmaceutical compositions comprising sitagliptin
EP4527467A3 (en) Pharmaceutical formulations
EP3743092A4 (en) Peptide yy pharmaceutical formulations, compositions, and methods
MX2020009857A (en) Il-2 conjugates.
PH12019501076A1 (en) Pharmaceutical formulations
ZA201902051B (en) Pharmaceutical composition
WO2019194773A3 (en) The combination comprising linagliptin and metformin
HK1254343A1 (en) Pharmaceutical formulations
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
MX2021010022A (en) Pharmaceutical composition.
ZA201902049B (en) Pharmaceutical composition
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
JOP20170137B1 (en) Physiologically balanced injectable formulations of fosnetupitant
WO2019240699A3 (en) Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion
EA201991287A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE
WO2020009675A3 (en) Solid oral pharmaceutical compositions of linagliptin
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
HK1245131A1 (en) Combination comprising palmitoylethanolamide (pea) and lycopene for use in the treatment of inflammatory diseases
ZA202204907B (en) Orally disintegrating pharmaceutical compositions of apixaban
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
MX2019001771A (en) Solid pharmaceutical composition comprising amorphous sofosbuvir.
EP4034120A4 (en) Solid oral pharmaceutical formulations comprising sapropterin dihydrochloride and at least one pharmaceutical excipient
WO2020190900A8 (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
EA201991007A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON LURAZIDONE HYDROCHLORIDE FOR ORAL USE

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019788122

Country of ref document: EP

Effective date: 20201117

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19788122

Country of ref document: EP

Kind code of ref document: A2